2.50
Hdl Handle:
http://hdl.handle.net/10755/243229
Category:
Abstract
Type:
Presentation
Title:
Symptom Clusters in Non-Small Cell Lung Cancer Taiwanese Patients
Author(s):
Wang, Shu-Yi; Lin, Chia-Chin
Author Details:
Wang, Shu-Yi, PhD, RN, CNS, shuyi@tmu.edu.tw; Lin, Chia-Chin, PhD;
Abstract:
Purpose:

Prior studies suggested that many symptoms are correlated with each other and called a symptom cluster. The underlying biologic mechanisms related to symptoms interrelated to symptoms are still unknown. The cytokine-induced sickness behavior that occurs in animals has much in common with the symptoms experienced by cancer patients. It is likely that symptoms may have natural associations with each other that reflect the underlying cytokines’ mechanisms, yet descriptive studies of the symptoms of lung cancer patients are far from comprehensive. Gefitinib (ZD 1839) is an orally active agent for patients with non-small cell lung cancer and was associated with disease stabilization and amelioration of cancer-related symptoms. The role for cytokines in symptoms relief after Gefitinib treatment remains unknown. The purpose of this study were (1).to investigate level of symptom distress and level of cytokines in advanced non-small cell lung cancer patients at pre-treatment, and 1, 3, and 6 months after receiving Gefitnib treatment; (2).to analysis the relationship between single symptoms/symptom clusters and cytokines in advanced non-small cell lung cancer patients at pre-treatment, and 1, 3, and 6 months after receiving Gefitnib treatment.

Methods:

Included the MD Anderson Symptom Inventory-Taiwan form and ELISA. Statistical analyses included descriptive statistics, Pearson’s correlation, and GEE analysis.

Results:

Results showed a positive correlation between nausea, drowsy, lack of appetite, sum of symptom severity, and symptom cluster two and IL-2; positive correlation between IL-6 and sadness, lack of appetite, nausea, and pain; positive correlation between IL-10 and fatigue, lack of appetite, drowsy, sadness, sum of symptom severity and symptom cluster one, and positive correlation between IL-12 and lack of appetite and nausea. There was a negative correlation between TNF-α and lack of appetite. 

Conclusion:

These results may provide a touchstone for understand the possible mechanisms of symptom distress in patients with non-small cell lung cancer.

Keywords:
TYPE NEW KEYWORD HERE; TYPE NEW KEYWORD HERE; TYPE NEW KEYWORD HERE
Repository Posting Date:
12-Sep-2012
Date of Publication:
12-Sep-2012
Conference Date:
2012
Conference Name:
23rd International Nursing Research Congress
Conference Host:
Sigma Theta Tau International, the Honor Society of Nursing
Conference Location:
Brisbane, Australia

Full metadata record

DC FieldValue Language
dc.type.categoryAbstracten_GB
dc.typePresentationen_GB
dc.titleSymptom Clusters in Non-Small Cell Lung Cancer Taiwanese Patientsen_GB
dc.contributor.authorWang, Shu-Yien_GB
dc.contributor.authorLin, Chia-Chinen_GB
dc.author.detailsWang, Shu-Yi, PhD, RN, CNS, shuyi@tmu.edu.tw; Lin, Chia-Chin, PhD;en_GB
dc.identifier.urihttp://hdl.handle.net/10755/243229-
dc.description.abstract<b>Purpose: </b> <div></div> <div></div><p>Prior studies suggested that many symptoms are correlated with each other and called a symptom cluster. The underlying biologic mechanisms related to symptoms interrelated to symptoms are still unknown. The cytokine-induced sickness behavior that occurs in animals has much in common with the symptoms experienced by cancer patients. It is likely that symptoms may have natural associations with each other that reflect the underlying cytokines&rsquo; mechanisms, yet descriptive studies of the symptoms of lung cancer patients are far from comprehensive. Gefitinib (ZD 1839) is an orally active agent for patients with non-small cell lung cancer and was associated with disease stabilization and amelioration of cancer-related symptoms. The role for cytokines in symptoms relief after Gefitinib treatment remains unknown. The purpose of this study were (1).to investigate level of symptom distress and level of cytokines in advanced non-small cell lung cancer patients at pre-treatment, and 1, 3, and 6 months after receiving Gefitnib treatment; (2).to analysis the relationship between single symptoms/symptom clusters and cytokines in advanced non-small cell lung cancer patients at pre-treatment, and 1, 3, and 6 months after receiving Gefitnib treatment. <p><b>Methods: </b> <p>Included the MD Anderson Symptom Inventory-Taiwan form and ELISA. Statistical analyses included descriptive statistics, Pearson&rsquo;s correlation, and GEE analysis. <p><b>Results: </b> <p>Results showed a positive correlation between nausea, drowsy, lack of appetite, sum of symptom severity, and symptom cluster two and IL-2; positive correlation between IL-6 and sadness, lack of appetite, nausea, and pain; positive correlation between IL-10 and fatigue, lack of appetite, drowsy, sadness, sum of symptom severity and symptom cluster one, and positive correlation between IL-12 and lack of appetite and nausea. There was a negative correlation between TNF-&alpha; and lack of appetite.&nbsp; <p><b>Conclusion: </b> <p>These results may provide a touchstone for understand the possible mechanisms of symptom distress in patients with non-small cell lung cancer.en_GB
dc.subjectTYPE NEW KEYWORD HEREen_GB
dc.subjectTYPE NEW KEYWORD HEREen_GB
dc.subjectTYPE NEW KEYWORD HEREen_GB
dc.date.available2012-09-12T09:19:19Z-
dc.date.issued2012-09-12-
dc.date.accessioned2012-09-12T09:19:19Z-
dc.conference.date2012en_GB
dc.conference.name23rd International Nursing Research Congressen_GB
dc.conference.hostSigma Theta Tau International, the Honor Society of Nursingen_GB
dc.conference.locationBrisbane, Australiaen_GB
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.